Skip to main content

Table 1 Outcomes of patients undergoing SRS for BM from SCLC

From: Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients

First author & year

Treatment modality

No. of Patients

No. receiving prior WBRT (%)

MST after SRS (months)

Local tumor control

Remote brain recurrence

Wegner 2011 [9]

GK

44

30 (68)

9

90%/1 year

61%/7 months

Jo 2011 [12]

GK

50

38 (76)

*6.3

70.3%/5.6 months

29.7% (crude)

Harris 2012 [13]

GK

51

34 (67)

5.9

57%/1 year

58%/1 year

Olson 2012 [10]

CK

27

19 (70)

3

76.5/1 year

60%/3.5 months

Nakazaki 2013 [11]

GK

44

44 (100)

5.8

95.8%/4 months

50%/6 months

Present study 2014

GK

70

24 (34)

7.8

77%/1 year

47%/1 year

  1. SRS stereotactic radiosurgery, BM brain metastasis, SCLC small cell lung cancer, WBRT whole brain radiotherapy, MST median survival time, GK gamma knife, CK cyberknife, *mean value.